The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy.

Clemens Nawara (First author), Gundula Rendl (Co-author), Karl Wurstbauer (Co-author), B Lackner, Lukas Rettenbacher (Co-author), L Datz, Michael Studnicka (Co-author), Felix Sedlmayer (Co-author), Christian Pirich* (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Articlepeer-review

9 Citations (Web of Science)
Original languageEnglish
Pages (from-to)19-201
JournalQUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume56
Issue number2
Publication statusPublished - 2012

Keywords

  • CELL LUNG-CANCER
  • POSITRON-EMISSION-TOMOGRAPHY
  • STANDARDIZED UPTAKE VALUE
  • FDG-PET
  • F-18-FDG PET
  • CONCURRENT CHEMORADIOTHERAPY
  • SEQUENTIAL CHEMORADIOTHERAPY
  • FLUORODEOXYGLUCOSE UPTAKE
  • INDUCTION CHEMOTHERAPY
  • INTEGRATED PET/CT

Cite this